{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:29:06Z","timestamp":1792790946747,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Shaanxi Provincial Philosophy and Social Science Research Project","award":["2024QN271"],"award-info":[{"award-number":["2024QN271"]}]},{"name":"the Shaanxi Provincial Sports Bureau Regular Project","award":["2023108"],"award-info":[{"award-number":["2023108"]}]},{"name":"the Teacher Education Reform and Development Research Project of Xi\u2019an Medical University","award":["2023JFY-31"],"award-info":[{"award-number":["2023JFY-31"]}],"id":[{"id":"https:\/\/ror.org\/01fmc2233","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the school-level scientific research fund from Xi\u2019an Medical University","award":["2023BS21"],"award-info":[{"award-number":["2023BS21"]}],"id":[{"id":"https:\/\/ror.org\/01fmc2233","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72211-7","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:02:30Z","timestamp":1726444950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between intensive blood pressure lowering and stroke-free survival among patients with and without Diabetes"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"72211_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O'Donnell","year":"2016","unstructured":"O\u2019Donnell, M. J. et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet 388, 761\u2013775 (2016).","journal-title":"Lancet"},{"key":"72211_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/svn-2016-000020","volume":"1","author":"JP Appleton","year":"2016","unstructured":"Appleton, J. P., Sprigg, N. & Bath, P. M. Blood pressure management in acute stroke. Stroke Vasc. Neurol. 1, 72\u201382 (2016).","journal-title":"Stroke Vasc. Neurol."},{"key":"72211_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40256-015-0129-0","volume":"15","author":"BN Mukete","year":"2015","unstructured":"Mukete, B. N., Cassidy, M., Ferdinand, K. C. & Le Jemtel, T. H. Long-term anti-hypertensive therapy and stroke prevention: A meta-analysis. Am. J. Cardiovasc. Drugs 15, 243\u2013257 (2015).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"72211_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet 387, 957\u2013967 (2016).","journal-title":"Lancet"},{"key":"72211_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","volume":"69","author":"AH Katsanos","year":"2017","unstructured":"Katsanos, A. H. et al. Blood pressure reduction and secondary stroke prevention: A systematic review and metaregression analysis of randomized clinical trials. Hypertension 69, 171\u2013179 (2017).","journal-title":"Hypertension"},{"key":"72211_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"Group AS","year":"2010","unstructured":"Group AS et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1575\u20131585 (2010).","journal-title":"N. Engl. J. Med."},{"key":"72211_CR7","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"Group SR","year":"2015","unstructured":"Group SR et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103\u20132116 (2015).","journal-title":"N. Engl. J. Med."},{"key":"72211_CR8","doi-asserted-by":"publisher","first-page":"k4245","DOI":"10.1136\/bmj.k4245","volume":"363","author":"DM Kent","year":"2018","unstructured":"Kent, D. M., Steyerberg, E. & van Klaveren, D. Personalized evidence based medicine: Predictive approaches to heterogeneous treatment effects. BMJ 363, k4245 (2018).","journal-title":"BMJ"},{"key":"72211_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7326\/M18-3667","volume":"172","author":"DM Kent","year":"2020","unstructured":"Kent, D. M. et al. The predictive approaches to treatment effect heterogeneity (PATH) statement. Ann. Intern. Med. 172, 35\u201345 (2020).","journal-title":"Ann. Intern. Med."},{"key":"72211_CR10","first-page":"2184","volume":"45","author":"IJ Dahabreh","year":"2016","unstructured":"Dahabreh, I. J., Hayward, R. & Kent, D. M. Using group data to treat individuals: Understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. Int. J. Epidemiol. 45, 2184\u20132193 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"72211_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamacardio.2021.4932","volume":"7","author":"ZR McCaw","year":"2022","unstructured":"McCaw, Z. R. et al. Practical recommendations on quantifying and interpreting treatment effects in the presence of terminal competing risks: A review. JAMA Cardiol. 7, 450\u2013456 (2022).","journal-title":"JAMA Cardiol."},{"key":"72211_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.2021.0987","volume":"325","author":"F Locatelli","year":"2021","unstructured":"Locatelli, F. et al. Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: A randomized clinical trial. JAMA 325, 843\u2013854 (2021).","journal-title":"JAMA"},{"key":"72211_CR13","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.2022.6147","volume":"327","author":"PJ Goodwin","year":"2022","unstructured":"Goodwin, P. J. et al. Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: The MA32 randomized clinical trial. JAMA 327, 1963\u20131973 (2022).","journal-title":"JAMA"},{"key":"72211_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/CIRCULATIONAHA.115.021275","volume":"135","author":"C Dufouil","year":"2017","unstructured":"Dufouil, C. et al. Revised Framingham Stroke risk profile to reflect temporal trends. Circulation 135, 1145\u20131159 (2017).","journal-title":"Circulation"},{"key":"72211_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/STROKEAHA.117.018928","volume":"49","author":"P Flueckiger","year":"2018","unstructured":"Flueckiger, P., Longstreth, W., Herrington, D. & Yeboah, J. Revised Framingham stroke risk score, nontraditional risk markers, and incident stroke in a multiethnic cohort. Stroke 49, 363\u2013369 (2018).","journal-title":"Stroke"},{"key":"72211_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903\u20131913 (2002).","journal-title":"Lancet"},{"key":"72211_CR17","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1016\/S2214-109X(18)30217-1","volume":"6","author":"B Lacey","year":"2018","unstructured":"Lacey, B. et al. Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 05 million adults in China: A prospective cohort study. Lancet Glob. Health 6, e641\u2013e649 (2018).","journal-title":"Lancet Glob. Health"},{"key":"72211_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","volume":"384","author":"BPLTT Collaboration","year":"2014","unstructured":"Collaboration, B. P. L. T. T. Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data. The Lancet 384, 591\u2013598 (2014).","journal-title":"The Lancet"},{"key":"72211_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","volume":"133","author":"PC Austin","year":"2016","unstructured":"Austin, P. C., Lee, D. S. & Fine, J. P. Introduction to the analysis of survival data in the presence of competing risks. Circulation 133, 601\u2013609 (2016).","journal-title":"Circulation"},{"key":"72211_CR20","doi-asserted-by":"publisher","first-page":"g5060","DOI":"10.1136\/bmj.g5060","volume":"349","author":"M Wolkewitz","year":"2014","unstructured":"Wolkewitz, M., Cooper, B. S., Bonten, M. J., Barnett, A. G. & Schumacher, M. Interpreting and comparing risks in the presence of competing events. BMJ 349, g5060 (2014).","journal-title":"BMJ"},{"key":"72211_CR21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/sim.7215","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin, P. C. & Fine, J. P. Accounting for competing risks in randomized controlled trials: A review and recommendations for improvement. Stat. Med. 36, 1203\u20131209 (2017).","journal-title":"Stat. Med."},{"key":"72211_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/jamacardio.2018.0127","volume":"3","author":"L Zhao","year":"2018","unstructured":"Zhao, L. et al. Estimating treatment effect with clinical interpretation from a comparative clinical trial with an end point subject to competing risks. JAMA Cardiol. 3, 357\u2013358 (2018).","journal-title":"JAMA Cardiol."},{"key":"72211_CR23","doi-asserted-by":"publisher","first-page":"106145","DOI":"10.1016\/j.cct.2020.106145","volume":"97","author":"ZR McCaw","year":"2020","unstructured":"McCaw, Z. R. et al. Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19. Contemp. Clin. Trials 97, 106145 (2020).","journal-title":"Contemp. Clin. Trials"},{"key":"72211_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0140-6736(05)70240-3","volume":"365","author":"R Jackson","year":"2005","unstructured":"Jackson, R., Lawes, C. M., Bennett, D. A., Milne, R. J. & Rodgers, A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual\u2019s absolute cardiovascular risk. Lancet 365, 434\u2013441 (2005).","journal-title":"Lancet"},{"key":"72211_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone, N. J. et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129, S1-45 (2014).","journal-title":"Circulation"},{"key":"72211_CR26","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 71, 2199\u20132269 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"72211_CR27","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/STROKEAHA.110.586222","volume":"41","author":"KL Chien","year":"2010","unstructured":"Chien, K. L. et al. Constructing the prediction model for the risk of stroke in a Chinese population: Report from a cohort study in Taiwan. Stroke 41, 1858\u20131864 (2010).","journal-title":"Stroke"},{"key":"72211_CR28","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2021.02.058","volume":"77","author":"AP Bress","year":"2021","unstructured":"Bress, A. P. et al. Patient selection for intensive blood pressure management based on benefit and adverse events. J. Am. Coll. Cardiol. 77, 1977\u20131990 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"72211_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamaneurol.2019.1141","volume":"76","author":"AC Leasure","year":"2019","unstructured":"Leasure, A. C. et al. Association of intensive blood pressure reduction with risk of hematoma expansion in patients with deep intracerebral hemorrhage. JAMA Neurol. 76, 949\u2013955 (2019).","journal-title":"JAMA Neurol."},{"key":"72211_CR30","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.120.16027","volume":"77","author":"CB Wright","year":"2021","unstructured":"Wright, C. B. et al. Effect of intensive versus standard blood pressure control on stroke subtypes. Hypertension 77, 1391\u20131398 (2021).","journal-title":"Hypertension"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72211-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72211-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72211-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T11:06:38Z","timestamp":1726830398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72211-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72211"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72211-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21551"}}